Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 3011260)

1.

Possible mitoxantrone-induced amenorrhea.

Shenkenberg TD, Von Hoff DD.

Cancer Treat Rep. 1986 May;70(5):659-61.

PMID:
3011260
2.

Reversible busulfan-induced ovarian failure.

Shalev O, Rahav G, Milwidsky A.

Eur J Obstet Gynecol Reprod Biol. 1987 Nov;26(3):239-42.

PMID:
2828130
3.

The gonadotrophin resistant ovary syndrome: a curable disease?

Evers JL, Rolland R.

Clin Endocrinol (Oxf). 1981 Jan;14(1):99-103.

PMID:
6784984
4.

Letter: Premature ovarian failure and the "gonadotropin-resistant" ovary syndrome.

Goldenberg RL.

Am J Obstet Gynecol. 1975 Jun 15;122(4):539-40. No abstract available.

PMID:
1146916
5.

Effects of synthetic luteinizing hormone-releasing hormone on plasma luteinizing hormone and follicle-stimulating hormone in amenorrheic women.

Rannevik G, Jeppsson S, Kullander S, Thorell J.

Fertil Steril. 1974 Jul;25(7):547-55. No abstract available.

PMID:
4601915
6.

Laparoscopic ovarian biopsy in hypergonadotropic amenorrhea.

Zara C, Bulgarelli C, Montanari L.

Acta Eur Fertil. 1987 Jan-Feb;18(1):49-53.

PMID:
2957883
7.

[Menstrual abnormality in patients with breast cancer receiving adjuvant endocrine-chemotherapy].

Yasumura T, Oka T, Honjo H, Okada H.

Gan To Kagaku Ryoho. 1988 Oct;15(10):2947-52. Japanese.

PMID:
3140733
8.

[Effect of chemotherapy to ovary function in ovarian malignancy patients undergoing conservative surgery].

Sun ZY, Shen K, Lang JH, Huang HF.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Aug;25(4):431-3. Chinese.

PMID:
12974089
9.
10.
11.

Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.

Hochner-Celnikier D, Zylber-Haran E, Shilo S, Palti Z, Spitz IM.

Obstet Gynecol. 1982 Mar;59(3):280-4.

PMID:
6804899
12.
13.

Idiopathic premature ovarian failure: clinical and endocrine characteristics.

Rebar RW, Erickson GF, Yen SS.

Fertil Steril. 1982 Jan;37(1):35-41.

PMID:
6800842
14.

The risk of premature menopause induced by chemotherapy for early breast cancer.

Lower EE, Blau R, Gazder P, Tummala R.

J Womens Health Gend Based Med. 1999 Sep;8(7):949-54.

PMID:
10534297
15.

Restoration of menstruation after chemotherapy-induced amenorrhoea in a patient with ovarian immature teratoma.

Iha T, Kano M, Nakayama M, Nagai Y, Moromizato H, Kanazawa K.

Eur J Obstet Gynecol Reprod Biol. 2001 Oct;98(2):249-50.

PMID:
11574141
16.

Luteinizing hormone releasing hormone analogue in treatment of hypergonadotrophic amenorrhoea.

Menon V, Edwards RL, Lynch SS, Butt WR.

Br J Obstet Gynaecol. 1983 Jun;90(6):539-42.

PMID:
6407517
17.

[Role of pulsatile liberation of gonadotropins in the development of amenorrhea].

Hámori M, Szendei G, Urbancsek J.

Zentralbl Gynakol. 1987;109(12):783-7. German.

PMID:
3115000
18.

Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure.

Coulam CB, Ryan RJ.

Am J Reprod Immunol Microbiol. 1985 Sep;9(1):23-4.

PMID:
3931487
19.

Prospects for fertility after chemotherapy or radiation for neoplastic disease.

Damewood MD, Grochow LB.

Fertil Steril. 1986 Apr;45(4):443-59. No abstract available.

PMID:
3082680
20.

Plasma oestradiol response to synthetic follicle stimulating hormone-luteinizing hormone in patients with secondary amenorrhoea.

Katz M, Carr PJ.

J Obstet Gynaecol Br Commonw. 1974 Oct;81(10):791-4. No abstract available.

PMID:
4608524
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk